AbbVie is reportedly buying Apogee Therapeutics for about $11 billion, adding a late‑stage eczema drug and deepening its immunology pipeline in North Chicago.

UT Austin engineers turned a hydrogel textile into a jacket that harvests drinkable water from the air — tests show survival-scale yields and a path toward commercialization.

Gene‑edited GalSafe pigs remove the sugar that causes some red‑meat allergies and have FDA clearance. Limited pork is being shared with patients while regulators and ethicists debate next steps.